A new study published in Molecular Psychiatry shows that computer-assisted cognitive behavioural therapy can cut depression symptoms in half, while also reshaping brain connections linked to mood ...

When people think of patients being treated for depression, usually what comes to mind is someone sitting in weekly therapy sessions, and perhaps being prescribed a medication. But some clinicians and ...

Assessing the brain at the Barbican, London, UK. Image by Tim Sandle. Assessing the brain at the Barbican, London, UK. Image by Tim Sandle. The medical benefits of mild electrical stimulation of the ...

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study. A device that delivers direct stimulation to ...

The at-home brain stimulation device is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has cleared Flow, a prescription home-based cranial ...

Flow Neuroscience has secured FDA approval for its at-home brain stimulation device, the FL-100 wearable device, as a non-invasive treatment for major depressive disorder (MDD). FL-100 is based on a ...

For Americans struggling with depression, a new door has opened: the FDA has authorized the first fully remote at-home brain stimulation treatment, following a study demonstrating its safety and ...

The US Food and Drug Administration has approved the first at-home brain stimulation device for treating depression, detailing how the Flow Neuroscience headset works, the science behind its approval, ...

In everyday language, the word depression is used in diverse ways and can refer to anything from passing feelings of sadness and unhappiness to chronic grief and deep despair. When clinicians and ...

Depression and anxiety are common in the U.S. Managing anxiety and depression takes daily work, and small additions or changes to your living spaces and routine may help, but they won’t replace ...

Amanda Ellison does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...